Deutsche Bank AG Has $25.78 Million Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Deutsche Bank AG raised its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 11,464.0% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 650,128 shares of the company's stock after buying an additional 644,506 shares during the period. Deutsche Bank AG owned about 0.70% of Acadia Healthcare worth $25,778,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the business. FMR LLC lifted its position in shares of Acadia Healthcare by 257.9% in the fourth quarter. FMR LLC now owns 6,230,631 shares of the company's stock worth $247,045,000 after purchasing an additional 4,489,681 shares in the last quarter. Khrom Capital Management LLC acquired a new stake in shares of Acadia Healthcare during the 4th quarter valued at $49,602,000. Balyasny Asset Management L.P. purchased a new position in shares of Acadia Healthcare during the 4th quarter valued at $43,092,000. Freestone Grove Partners LP purchased a new stake in shares of Acadia Healthcare during the fourth quarter worth $29,943,000. Finally, Magnetar Financial LLC grew its stake in Acadia Healthcare by 385.4% in the fourth quarter. Magnetar Financial LLC now owns 928,772 shares of the company's stock valued at $36,826,000 after purchasing an additional 737,427 shares in the last quarter.

Acadia Healthcare Stock Performance

Shares of ACHC stock traded up $0.17 during mid-day trading on Tuesday, reaching $25.25. The stock had a trading volume of 284,017 shares, compared to its average volume of 1,702,670. The firm has a market cap of $2.33 billion, a PE ratio of 8.27, a P/E/G ratio of 1.46 and a beta of 1.01. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare Company, Inc. has a one year low of $20.36 and a one year high of $82.41. The firm's 50 day simple moving average is $26.12 and its 200 day simple moving average is $35.37.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its earnings results on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.05. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business had revenue of $770.51 million for the quarter, compared to analyst estimates of $769.90 million. During the same period in the previous year, the business earned $0.84 EPS. The firm's revenue was up .3% on a year-over-year basis. On average, analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Analyst Ratings Changes

ACHC has been the topic of several recent research reports. Mizuho cut their price objective on shares of Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating on the stock in a research report on Wednesday, May 14th. Barclays cut their target price on Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating on the stock in a report on Wednesday, May 14th. KeyCorp lowered their price objective on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a report on Wednesday, May 14th. Guggenheim assumed coverage on shares of Acadia Healthcare in a research note on Wednesday, April 9th. They issued a "buy" rating and a $36.00 price objective for the company. Finally, Bank of America lowered their target price on shares of Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating on the stock in a research note on Friday, February 28th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $47.94.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.